Terms: = Liver cancer AND HNF1A, HNF1, 6927, ENSG00000135100, TCF1, MODY3, P20823, LFB1 AND Diagnosis
29 results:
1. Hepatic adenoma in a 7-year-old girl: a case report and literature review.
Gao Y; Zhou J; Xie YC; Qiu LJ; Duan L; A ZX; Wu HF; Lv MX
BMC Pediatr; 2023 Aug; 23(1):420. PubMed ID: 37620840
[TBL] [Abstract] [Full Text] [Related]
2. Body weight changes and duration of estrogen exposure modulate the evolution of hepatocellular adenomas after contraception discontinuation.
Demory A; Péron JM; Calderaro J; Selves J; Mokrane FZ; Amaddeo G; Paradis V; Ziol M; Sutter O; Blaise L; Ganne-Carrié N; Vilgrain V; Cauchy F; Zucman-Rossi J; Ronot M; Nault JC
Hepatology; 2023 Feb; 77(2):430-442. PubMed ID: 35980227
[TBL] [Abstract] [Full Text] [Related]
3. Benign liver tumours: understanding molecular physiology to adapt clinical management.
Nault JC; Paradis V; Ronot M; Zucman-Rossi J
Nat Rev Gastroenterol Hepatol; 2022 Nov; 19(11):703-716. PubMed ID: 35835851
[TBL] [Abstract] [Full Text] [Related]
4. Morphomolecular Classification Update on Hepatocellular Adenoma, Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma.
Katabathina VS; Khanna L; Surabhi VR; Minervini M; Shanbhogue K; Dasyam AK; Prasad SR
Radiographics; 2022; 42(5):1338-1357. PubMed ID: 35776676
[TBL] [Abstract] [Full Text] [Related]
5. Direct Conversion of Human Endothelial Cells Into liver cancer-Forming Cells Using Nonintegrative Episomal Vectors.
Goya T; Horisawa K; Udono M; Ohkawa Y; Ogawa Y; Sekiya S; Suzuki A
Hepatol Commun; 2022 Jul; 6(7):1725-1740. PubMed ID: 35220676
[TBL] [Abstract] [Full Text] [Related]
6.
Young JR; Graham RP; Venkatesh SK; Kendi AT
Abdom Radiol (NY); 2021 Jun; 46(6):2604-2609. PubMed ID: 33555390
[TBL] [Abstract] [Full Text] [Related]
7. Hepatocellular adenomas: review of pathological and molecular features.
Beaufrère A; Paradis V
Hum Pathol; 2021 Jun; 112():128-137. PubMed ID: 33307077
[TBL] [Abstract] [Full Text] [Related]
8. ASTN1 is associated with immune infiltrates in hepatocellular carcinoma, and inhibits the migratory and invasive capacity of liver cancer via the Wnt/β‑catenin signaling pathway.
Chen QF; Shi F; Huang T; Huang C; Shen L; Wu P; Li W
Oncol Rep; 2020 Oct; 44(4):1425-1440. PubMed ID: 32945491
[TBL] [Abstract] [Full Text] [Related]
9. Myxoid hepatocellular adenoma, a rare variant of hepatocellular adenoma with distinct imaging features: A case report with immunohistochemical and molecular analysis and literature review.
De Vos N; Van der Meulen J; Van Der Linden M; Claes K; Candaele AS; Vanlander A; Troisi RI; Van Vlierberghe H; Smeets P; Van Dorpe J; Hoorens A
Clin Res Hepatol Gastroenterol; 2021 May; 45(3):101478. PubMed ID: 32620388
[TBL] [Abstract] [Full Text] [Related]
10. Association of Common Variants in hnf1a Gene with Serum AFP Level in Healthy Chinese Individuals and HCC Patients.
Li XJ; Shao DH; He ML; Liang GW
Dis Markers; 2019; 2019():6273497. PubMed ID: 31915469
[TBL] [Abstract] [Full Text] [Related]
11. diagnosis of hepatocellular adenoma in men before onset of diabetes in hnf1a-MODY: Watch out for winkers.
Haring MPD; Vriesendorp TM; Klein Wassink-Ruiter JS; de Haas RJ; Gouw ASH; de Meijer VE
Liver Int; 2019 Nov; 39(11):2042-2045. PubMed ID: 31483937
[TBL] [Abstract] [Full Text] [Related]
12. Natural history of liver adenomatosis: A long-term observational study.
Barbier L; Nault JC; Dujardin F; Scotto B; Besson M; de Muret A; Bourlier P; Zucman-Rossi J; Salamé E; Bacq Y
J Hepatol; 2019 Dec; 71(6):1184-1192. PubMed ID: 31419515
[TBL] [Abstract] [Full Text] [Related]
13. Repeat surgery in hnf1alpha-inactivated adenomatosis.
Balabaud C; Laurent C; Frulio N; Marie Christine SP; Le Bail B; Possenti L; Blanc JF; Chiche L; Bioulac-Sage P
Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):460-467. PubMed ID: 30902584
[TBL] [Abstract] [Full Text] [Related]
14. Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions.
Reizine E; Amaddeo G; Pigneur F; Baranes L; Legou F; Mulé S; Zegai B; Roche V; Laurent A; Rahmouni A; Calderaro J; Luciani A
Eur Radiol; 2018 Oct; 28(10):4243-4253. PubMed ID: 29721686
[TBL] [Abstract] [Full Text] [Related]
15. Molecular classification of hepatocellular adenoma in clinical practice.
Nault JC; Paradis V; Cherqui D; Vilgrain V; Zucman-Rossi J
J Hepatol; 2017 Nov; 67(5):1074-1083. PubMed ID: 28733222
[TBL] [Abstract] [Full Text] [Related]
16. Hepatic adenomas with synchronous or metachronous fibrolamellar carcinomas: both are characterized by LFABP loss.
Graham RP; Terracciano LM; Meves A; Vanderboom PM; Dasari S; Yeh MM; Torbenson MS; Cruise MW
Mod Pathol; 2016 Jun; 29(6):607-15. PubMed ID: 27015136
[TBL] [Abstract] [Full Text] [Related]
17. Expression of liver fatty acid binding protein in hepatocellular carcinoma.
Cho SJ; Ferrell LD; Gill RM
Hum Pathol; 2016 Apr; 50():135-9. PubMed ID: 26997447
[TBL] [Abstract] [Full Text] [Related]
18. liver biopsy for diagnosis of presumed benign hepatocellular lesions lacking magnetic resonance imaging diagnostic features of focal nodular hyperplasia.
Sannier A; Cazejust J; Lequoy M; Cervera P; Scatton O; Rosmorduc O; Wendum D
Liver Int; 2016 Nov; 36(11):1668-1676. PubMed ID: 26969817
[TBL] [Abstract] [Full Text] [Related]
19. PET-avid hepatocellular adenomas: incidental findings associated with hnf1-α mutated lesions.
Lee SY; Kingham TP; LaGratta MD; Jessurun J; Cherqui D; Jarnagin WR; Kluger MD
HPB (Oxford); 2016 Jan; 18(1):41-8. PubMed ID: 26776850
[TBL] [Abstract] [Full Text] [Related]
20. Inflammatory hepatocellular adenomas developed in the setting of chronic liver disease and cirrhosis.
Calderaro J; Nault JC; Balabaud C; Couchy G; Saint-Paul MC; Azoulay D; Mehdaoui D; Luciani A; Zafrani ES; Bioulac-Sage P; Zucman-Rossi J
Mod Pathol; 2016 Jan; 29(1):43-50. PubMed ID: 26516697
[TBL] [Abstract] [Full Text] [Related]
[Next]
